Aurdan Capital Management LLC Invests $1.10 Million in Aflac Incorporated (NYSE:AFL)

Aurdan Capital Management LLC purchased a new stake in Aflac Incorporated (NYSE:AFL - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 10,600 shares of the financial services provider's stock, valued at approximately $1,096,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AFL. Whipplewood Advisors LLC purchased a new position in shares of Aflac during the 4th quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Aflac during the 4th quarter valued at about $34,000. Curio Wealth LLC purchased a new position in shares of Aflac during the 4th quarter valued at about $36,000. OFI Invest Asset Management purchased a new position in shares of Aflac during the 4th quarter valued at about $38,000. Finally, Rialto Wealth Management LLC purchased a new position in shares of Aflac during the 4th quarter valued at about $41,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Insider Transactions at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now owns 49,962 shares in the company, valued at $5,360,422.98. This trade represents a 37.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the transaction, the director now owns 26,096 shares in the company, valued at $2,786,791.84. This represents a 3.69% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 71,552 shares of company stock valued at $7,609,382. Corporate insiders own 0.80% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on AFL shares. Raymond James reduced their price objective on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a research note on Thursday. Barclays upped their price objective on Aflac from $95.00 to $96.00 and gave the company an "underweight" rating in a report on Thursday, May 1st. Piper Sandler upped their price target on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. UBS Group upped their price target on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Finally, Wells Fargo & Company upped their price target on Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $104.93.

Aflac Trading Up 0.7%

Shares of NYSE:AFL traded up $0.70 during trading on Friday, hitting $103.51. 782,208 shares of the company's stock were exchanged, compared to its average volume of 2,110,398. Aflac Incorporated has a 1-year low of $86.46 and a 1-year high of $115.50. The firm has a 50-day moving average price of $106.27 and a two-hundred day moving average price of $106.26. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The firm has a market cap of $55.96 billion, a P/E ratio of 10.78, a PEG ratio of 3.24 and a beta of 0.84.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 28.76% and a return on equity of 16.20%. The firm had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. During the same quarter in the prior year, the firm posted $1.66 EPS. The firm's revenue for the quarter was down 37.5% compared to the same quarter last year. Equities analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st will be given a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.24%. The ex-dividend date is Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.